Multimodal peripheral fluid biomarker analysis in clinically isolated syndrome and early multiple sclerosis
- 2 February 2021
- journal article
- research article
- Published by Elsevier BV in Multiple Sclerosis and Related Disorders
- Vol. 50, 102809
- https://doi.org/10.1016/j.msard.2021.102809
Abstract
No abstract availableFunding Information
- Government of Alberta
This publication has 36 references indexed in Scilit:
- B cells undergo unique compartmentalized redistribution in multiple sclerosisJournal of Autoimmunity, 2011
- Glutamate and ATP signalling in white matter pathologyJournal of Anatomy, 2011
- NMR‐based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases – a diagnostic tool?NMR in Biomedicine, 2009
- Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cellsBrain, 2008
- Targeted Profiling: Quantitative Analysis of 1H NMR Metabolomics DataAnalytical Chemistry, 2006
- Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosisBrain, 2003
- Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytesJournal of Autoimmunity, 2001
- Neurotransmitters in cerebrospinal fluid reflect pathological activityEuropean Journal of Clinical Investigation, 1997
- Cross-Validation of Regression ModelsJournal of the American Statistical Association, 1984
- Loss of Suppressor T Cells in Active Multiple SclerosisThe New England Journal of Medicine, 1980